Latest Breaking News On - Eamonn nolan - Page 6 : comparemela.com

EQS-News: MorphoSys Receives U S FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer

EQS-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys Receives U.S. FDA Fast Track Designation for Tulmime.

United statesEamonn nolanJulia neugebauerTim demuthThomas biegiXencor incExchange commissionDrug administrationAmerican society of clinical oncologyLymphoma societyDevelopment officerTrack designationFast trackClinical oncologyAnnual meetingMorphosys chief research

MorphoSys Receives U S FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer

MorphoSys Receives U S FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJulia neugebauerThomas biegiTim demuthEamonn nolanAmerican society of clinical oncologyDrug administrationExchange commissionLymphoma societyXencor incDevelopment officerFast trackClinical oncologyAnnual meetingMorphosys chief researchAntibody dependent cell mediated cytotoxicity

MorphoSys Receives U S FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer

EQS-News: MorphoSys AG / Key word: Miscellaneous MorphoSys Receives U.S. FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer 12.09.2023 / 22:01.

United statesJulia neugebauerEamonn nolanThomas biegiTim demuthDrug administrationDevelopment officerLymphoma societyAmerican society of clinical oncologyXencor incExchange commissionTrack designationFast trackClinical oncologyAnnual meetingMorphosys chief research

MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results

MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGeorge golumbeskiJean paul kressJulia neugebauerMonjuvi minjuviThomas biegiEamonn nolanMichael brosnanExchange commissionAmerican society of clinical oncologyXencor incShare of loss associatesMorphosys group key figuresJanssen biotech incEuropean hematology association

Invitation to MorphoSys Second Quarter and First Half 2023 Financial Results Conference Call on August 10, 2023

EQS-News: MorphoSys AG / Key word(s): Half Year ResultsInvitation to MorphoSys’ Second Quarter and First Half 2023 Financial Results Conference Call on August 10, 2023 03.08.2023 / 22:03 CET/CESTThe issuer is solely responsible for the content of this announcement.Conference Call AlertPlanegg/Munich, Germany, Augus.

United statesJulia neugebauerThomas biegiEamonn nolanDistribution servicesExchange commissionHalf year resultsMorphosy second quarterFirst halfResults conference callMorphosy annual reportCorporate newsRegulatory announcements